IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

a16z Capital Management, L.L.C.

Q4 2025 Holdings

Filed 2026-02-17 | 13 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Figma Inc(FIG)CLASS A COM STK316841105$607.1M16,246,12938.4%
Navan Inc(NAVN)CL A639193101$464.5M27,195,36429.4%
Meta Platforms Inc(META)CL A30303M102$140.3M212,5318.9%
Revolution Medicines Inc(RVMD)COM76155X100$73.4M921,0994.6%
Maze Therapeutics Inc(MAZE)COM578784100$70.5M1,702,2254.5%
Block Inc(XYZ)CL A852234103$66.2M1,016,6974.2%
Omada Health Inc(OMDA)COM68170A108$54.6M3,460,9293.5%
Bioage Labs Inc(BIOA)COM09077V100$44.1M3,233,1702.8%
Nautilus Biotechnology Inc(NAUT)COM63909J108$34.4M17,653,9172.2%
Camp4 Therapeutics Corp(CAMP)COM13463J101$13.0M2,125,3390.8%
Erasca Inc(ERAS)COM29479A108$10.6M2,862,5000.7%
Ginkgo Bioworks Holdings Inc(DNA)CL A NEW37611X209$902.2K108,5680.1%
Heritage Comm Corp(HTBK)COM426927109$129.1K82,7400.0%